Signify Health, Inc.
SGFY · NYSE
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | -1.46 | 7.43 | 32.74 |
| FCF Yield | 1.38% | 4.22% | 0.18% | 0.31% |
| EV / EBITDA | -178.65 | 15.52 | 64.01 | 61.91 |
| Quality | ||||
| ROIC | 8.28% | 2.23% | 1.96% | 1.70% |
| Gross Margin | 45.33% | 49.12% | 49.77% | 50.74% |
| Cash Conversion Ratio | -0.75 | 13.12 | -3.00 | -1.46 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.67% | 15.51% | 21.80% | 7,946,418.26% |
| Free Cash Flow Growth | -31.19% | 977.66% | -41.98% | -28.00% |
| Safety | ||||
| Net Debt / EBITDA | 3.75 | -2.56 | 3.78 | 2.74 |
| Interest Coverage | 5.29 | 2.85 | 1.11 | 1.02 |
| Efficiency | ||||
| Inventory Turnover | 3.67 | -4.67 | -11.03 | 0.00 |
| Cash Conversion Cycle | 175.25 | 58.90 | 144.46 | 144.96 |